MetaCap

Anixa Biosciences Statistics

NASDAQ: ANIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.44-0.16 (-6.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Anixa Biosciences by the numbers

Anixa Biosciences has a market capitalization of $84.8 million based on 34.76M shares outstanding. With trailing EPS of $-0.32, Anixa Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.5% below its 50-day average and 17.3% below its 200-day average.

Average daily trading volume is 282.29K shares, or about $688,785 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ANIX valuation vs. peer median

ANIX compared with the median of 8 peer companies
MetricANIXPeer medianDifference
Market cap$84.82M$84.71M+0%
Avg. volume282.29K556.08K-49%

Peer median across 8 companies: UPB, EQ, OGI, HURA, RTSN, CPIX, NKTX, TLSA.

Valuation

Price and trading

Previous close
2.60
Open
2.55
Day range
2.40 – 2.59
52-week range
2.32 – 5.46
52-week change
-43.78%
Beta
—
Volume
355.05K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
84.82M
Forward Pe
-7.87
Eps
-0.32
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.46
Week52 Low
2.32
Avg Volume
282.29K
Shares Outstanding
34.76M
Ma50
2.85
Ma200
2.95
Earnings Date
Sep 9, 2026
Pct From52w High
-55.31%
Pct From52w Low
5.17%

Related